[ERLPHD]

Greetings!

Since I am trying to learn as much as I can about the issues surrounding pharmaceutical risk management programs in an office-based practice (I am a research scientist), I figured what better place to seek insight from than this forum. From my readings on the internet, it seems that the iPLEDGE program for tretinoin would be a good place to start as it appears to have generated a lot of controversy since its inception.



Thanks in advance for your time and consideration.